MAPT and Alzheimer disease: Moreover, we also obtained significant (p < 0.001) moderate correlations between plasma p-Tau181 and the additional CSF-AD markers: Aβ42/Aβ40 ratio and t-Tau (ρ =  − 0.52 and ρ = 0.57, respectively; not shown).